Olon S.p.A.

Olon S.p.A., headquartered in Rodano, Italy, is a globally recognized leader in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. Established as a powerhouse of chemical and biological manufacturing, Olon integrates decades of industrial expertise with cutting-edge research to deliver high-quality generic APIs and Contract Development and Manufacturing Organization (CDMO) services.

With a vast global network comprising 11 manufacturing sites across Europe, the US, and India, along with 7 dedicated R&D centers, Olon offers unparalleled flexibility and scale. The company distinguishes itself through its dual expertise in complex chemical synthesis and advanced microbial fermentation. This unique combination allows Olon to produce a highly diversified portfolio of over 300 commercial APIs, ranging from standard small molecules to complex highly potent APIs (HPAPIs), retinoids, antivirals, and biologics.

Olon is particularly renowned for its state-of-the-art fermentation capabilities, which are crucial for the production of specialized antibiotics, immunosuppressants, and advanced biotechnological intermediates. The organization is deeply committed to continuous innovation and sustainability, heavily investing in green chemistry, biocatalysis, and continuous flow manufacturing to reduce environmental impact and optimize production costs.

Quality and compliance are fundamental to Olon’s operations, with all facilities adhering to the strictest cGMP standards and regularly inspected by leading regulatory bodies including the US FDA, AIFA, and PMDA. Through strategic acquisitions and continuous capability expansion, Olon has positioned itself as a trusted partner for both generic pharmaceutical companies and innovative biotech firms requiring end-to-end CDMO support from preclinical phases to commercial launch.